In patients with CRP < 1 mg/L, responders (again, vs. current MDD) show inhibition of interferon signalling, confirming and expanding upon previous RNA-seq findings identifying upregulation of genes in this pathway in people with MDD [23] or treatment-resistant depression [25] in comparison with controls. The gene discussed is CRP; the disease is depressive symptom measurement.